A client with congestive heart failure (CHF) is at risk of developing ascites due to fluid overload. Which of the following manifestations may indicate the presence of ascites in this client?

Choice A reason:

Muscle weakness and fatigue are not commonly associated with spironolactone use.

Choice B reason:

Increased urine output and dehydration may occur with diuretics, but spironolactone is a potassium-sparing diuretic, so excessive urine output and dehydration are less likely to occur with this medication.

Choice C reason:

Hypotension and dizziness are potential side effects of some diuretics, but they are not specific to spironolactone use.

Choice D reason:

This statement is correct. Spironolactone is a potassium-sparing diuretic, which means it can lead to hyperkalemia (elevated potassium levels) if not monitored carefully. Hyperkalemia can cause irregular heart rhythms and other serious complications.

Choice A reason:

This statement is correct. Weighing the client daily and recording the weight in the chart is an essential intervention to monitor fluid balance and detect any changes in body weight, which can indicate fluid retention or loss.

Choice B reason:

Measuring vital signs every four hours is important for assessing the client's overall condition, but it does not directly monitor fluid balance or hydration status.

Choice C reason:

Assessing urine output hourly is important, especially for clients with ascites who may have altered kidney function. However, it may not provide a comprehensive assessment of the client's overall fluid balance.

Choice D reason:

Restricting fluid intake may not be appropriate for all clients with ascites, as fluid restriction could lead to dehydration and further imbalances in fluid and electrolyte levels.